Posts Tagged ‘adherence’

AARDEX announces the world’s first DIGITAL MEDICATION ADHERENCE MONITORING solution fully integrated in the clinical trial platform by a top 10 pharma company.

AARDEX is proud to announce the integration of its MEMS® Adherence Software by a major pharmaceutical company. It’s the first end-to-end integration of electronically compiled dosing histories using smart packages from interactive response technology (IRT) into electronical data capture systems (EDC) to improve medication adherence data accuracy in clinical trials. This collaboration, initiated in 2015,…

Read More

AARDEX Group announces the opening of a new office in the U.S.

By establishing itself in the U.S., the Group aims to strengthen its business and maintain its position as market leader in digital adherence monitoring systems. Joe Keenan will lead the business development for the pharma and biotech industry in North America. With over 70% of AARDEX’s customers based in the U.S., this new office will support…

Read More

Using data science to detect key changes in medication intake behaviors.

Electronic monitoring, a digital technology based on smart packages, enables the most objective and precise adherence monitoring. By using an evidence-based digital adherence monitoring system, Sponsors and HCPs improve drug efficacy by managing patient adherence to the medications. In this Medium article (the online publishing platform), AARDEX presents the latest results from its data science…

Read More

How smart packages enable digital medication adherence monitoring for successful clinical trials?

50 % of patients involved in clinical trials do not take their medication as prescribed, resulting in underestimated drug efficacy and delayed approval of the investigational product. Poor medication adherence is thus a threat to drug development. Stop using unreliable methods to assess medication adherence and maximize the chances of success in your clinical trials…

Read More

How the EMERGE guideline on medication adherence can improve the quality of clinical trials

Recently, the FDA (Mar 2019) and the EMA (Feb 2020) have finalized guidances to monitor and mitigate the risk of patient non-adherence to the treatments tested in clinical trials. Under the auspices of the International Society for Medication Adherence (ESPACOMP), an international panel of experts established a set of reporting guidelines (EMERGE).  In this newest publication,…

Read More